Absci Corporation logo

Absci Corporation

NASDAQ:ABSI

Overview | Financials
Company Name Absci Corporation
Symbol ABSI
Currency USD
Price 3.01
Market Cap 345,716,560
Dividend Yield 0%
52-week-range 2.45 - 6.72
Industry Biotechnology
Sector Healthcare
CEO Mr. Sean McClain
Website https://www.absci.com

An error occurred while fetching data.

About Absci Corporation

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process.

Related Stocks

HilleVax, Inc. logo

HilleVax, Inc.

HLVX

1.87 USD

Heron Therapeutics, Inc. logo

Heron Therapeutics, Inc.

HRTX

1.58 USD

ALX Oncology Holdings Inc. logo

ALX Oncology Holdings Inc.

ALXO

1.83 USD

BioXcel Therapeutics, Inc. logo

BioXcel Therapeutics, Inc.

BTAI

0.351 USD

Fulcrum Therapeutics, Inc. logo

Fulcrum Therapeutics, Inc.

FULC

4.55 USD

C4 Therapeutics, Inc. logo

C4 Therapeutics, Inc.

CCCC

3.87 USD

Athira Pharma, Inc. logo

Athira Pharma, Inc.

ATHA

0.542 USD

OraSure Technologies, Inc. logo

OraSure Technologies, Inc.

OSUR

3.69 USD

EyePoint Pharmaceuticals, Inc. logo

EyePoint Pharmaceuticals, Inc.

EYPT

7.33 USD

Financials

Numbers are in millions USD

Numbers are in millions USD